FK 453
Alternative Names: FK 113453; FR 113453; FR 453Latest Information Update: 23 Jun 1998
At a glance
- Originator Fujisawa
- Class Antihypertensives; Neuroprotectants; Small molecules; Vasodilators
- Mechanism of Action Adenosine A1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension
Most Recent Events
- 23 Jun 1998 Commercial data has been reviewed by Fujisawa
- 23 Jun 1998 Discontinued-Preclinical for Heart failure in Japan (PO)
- 23 Jun 1998 Discontinued-Preclinical for Heart failure in United Kingdom (PO)